Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Miscellaneous and site unspecified neoplasms malignant and unspecified
ADR ID BADD_A02790
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
Description Not Available
MedDRA Code 10027655
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01937Rifapentine--
BADD_D01938Rifaximin0.001993%
BADD_D01942Riluzole--
BADD_D01943Rimabotulinumtoxinb--
BADD_D01948Riociguat0.000542%
BADD_D01950Risedronic acid--
BADD_D01951Risperidone--
BADD_D01954Rivaroxaban0.000792%
BADD_D01955Rivastigmine--
BADD_D01956Rivastigmine tartrate--
BADD_D01961Rofecoxib--
BADD_D01964Romidepsin--
BADD_D01966Ropinirole--
BADD_D01973Rotigotine0.000550%
BADD_D01978Ruxolitinib0.004186%
BADD_D01984Samarium--
BADD_D01987Sapropterin0.004312%
BADD_D01989Saquinavir mesylate--
BADD_D01992Saxagliptin0.000491%
BADD_D02002Selegiline--
BADD_D02006Selexipag0.000329%
BADD_D02007Semaxanib--
BADD_D02010Sertraline0.000051%
BADD_D02011Sertraline hydrochloride--
BADD_D02016Sibutramine--
BADD_D02018Sildenafil0.001450%
BADD_D02026Simvastatin0.000022%
BADD_D02028Sirolimus0.001166%
BADD_D02029Sitagliptin0.001008%
BADD_D02031Sitaxentan--
The 12th Page    First    Pre   12 13 14 15 16    Next   Last    Total 18 Pages